Persistent market archive
Finance, business, and economy headlines with related U.S. tickers, event materiality, publisher context, and links to the original source.
Tokyo, Nov. 5 (Jiji Press)--Most Bank of Japan policymakers shared concern that underlying inflation could exceed the central bank's 2 pct price stability target at their Sept. 17-18 meeting, at which the BOJ...
Danaher (DHR) has seen its stock fair value increase due to analysts raising price targets, with several now between US$260 and US$275. This optimism is driven by the company's 2027 core growth projections, Q3 2026 performance, and potential for improved margins and organic growth. The revised fair value estimate for Danaher has moved from US$244.14 to US$259.90.
SOCIETYByChris Boyette, Maria Aguilar Prieto Thursday, November 5, 2026 6:18AMStream Southern California's News Leader and Original Shows 24/7A lucky Powerball ticket in New Jersey has won an estimated $847...
YETI (NYSE:YETI) is scheduled to release its Q3 2026 earnings before market open on Thursday, November 12th, with analysts expecting $0.84 EPS on $523.21 million in revenue. The company previously beat estimates in Q2 2026, reporting $0.67 EPS against a $0.54 consensus. Analysts currently rate YETI stock a "Moderate Buy" with an average price target of $55.20.
Tuesday's midterm vote is behind us, and chip stocks came into it bruised. The VanEck Semiconductor ETF (SMH -2.75%) ended Election Day at $518.52. That was around 22% under the fund's highest close ever, set...
This article details conflicting analyst sentiments for three healthcare companies: Jazz Pharmaceuticals (JAZZ), Inspire Medical Systems (INSP), and Travere Therapeutics (TVTX). Stifel Nicolaus analysts reiterated a Buy rating for Jazz Pharmaceuticals and Inspire Medical Systems, while maintaining a Hold rating for Travere Therapeutics. The article provides individual analyst ratings, price targets, and overall Street consensus for each company.
ANI Pharmaceuticals has made a public offer to acquire Egetis Therapeutics for approximately SEK 5.6 billion ($560 million). The acquisition aims to expand ANI's rare disease business by adding EMCITATE, an approved treatment for MCT8 deficiency, which ANI estimates could achieve peak sales of over $300 million with patent protection extending into mid-2045. Egetis's board unanimously recommends the offer, and shareholders representing about 42% of outstanding shares have committed to accept, with the deal contingent on 90% shareholder acceptance and regulatory approvals.
ANI Pharmaceuticals has announced a recommended public offer to acquire Egetis Therapeutics AB for approximately $560 million. This acquisition aims to expand ANI's rare disease business, leveraging Egetis's lead asset, EMCITATE®, an approved treatment for MCT8 deficiency with an estimated peak sales potential of over $300 million. The deal is unanimously recommended by Egetis's Board and supported by shareholders controlling 42% of its shares.
USBC, Inc. has filed a Transition Report on Form 10-K for the quarter spanning October 1, 2025, to December 31, 2025, reflecting its fiscal year end adjustment from September 30 to December 31, effective fiscal year 2026. The report details the company's change to a calendar-year reporting structure to align with operational cycles and industry peers. It also highlights 388,144,429 outstanding shares, a non-affiliate market value of $14,110,017, and mentions its "tokenized cryptocurrency treasury strategy" and Bitcoin holdings.
Newmont CEO Natascha Viljoen, a South African mining engineer, disposed of 25,780 shares in the company valued at approximately $2.9 million between late October and early November. The majority of these shares were withheld for tax purposes related to restricted stock units vesting, with a smaller portion sold under a pre-arranged trading plan. Despite the sales, Viljoen retains a substantial stake in Newmont, worth about $11 million.
Argus has raised its price target for Tenet Healthcare Corporation (THC) to $293.00, citing the company's strong position in healthcare services. As of November 4, 2026, THC's current price is $292.25. Tenet Healthcare operates 47 acute and specialty hospitals and over 500 ambulatory surgery centers across the U.S., predominantly in the South.
Shares of Trump Media & Technology Group Corp., the owner of Truth Social in which President Donald Trump holds a 41% stake, fell to a record low on Wednesday after Republicans lost control of both...
Site search5 hours agoMichelle FleuryNew York business correspondentEPA/ShutterstockHouse Democrat leader Hakeem Jeffries said "now it's our job to govern on affordability"Two business owners, half a country...
After years as collateral damage in Donald Trump’s war on climate action, the Democrats’ sweeping triumph in the US midterm elections has emerged as a victory for the global renewable energy industry...
(Gray News) - A single ticket matched all numbers in Wednesday night’s Powerball drawing with an estimated jackpot of $847 million.The Nov. 4 winning Powerball numbers were 15, 34, 41, 53, 56 and the red...
Goldman Sachs increased its price target for Expedia Group Inc. shares to $320 from $310, maintaining a Buy rating, following Expedia's strong third-quarter 2026 earnings. The company's core operating metrics, including gross bookings, revenue, and adjusted EBITDA, surpassed expectations, driven by solid execution in both consumer and business-to-business segments, with AI investments also highlighted as a long-term opportunity.
Defiance ETFs, in conjunction with Tidal Financial Group, announced the closure and liquidation of three exchange-traded funds: ASTN, STSM, and RKLZ. This decision is part of Defiance's ongoing review of its product lineup to align with evolving market needs. The final trading day for these funds will be November 16, 2026, with liquidation occurring on November 20, 2026, at which point shares will be automatically redeemed for cash at NAV.
Food price rises in Europe have been modest this year, but fresh produce is getting pricier, with prices up 8% in France and supply disruptions leaving shelves empty in southern Italy.
CENTRAL Visayas’ inflation rate accelerated to 9.5 percent in October from 8.3 percent in September, outpacing the national average as food prices continued to rise, data from the Philippine Statistics...
HomeMarket OutlookCommodities SummaryOil markets sold off aggressively yesterday, with ICE Brent settling 8.7% lower on the day and below $95/bbl. Selling pressure has only continued in early morning trading...
Group Benefits Aetna will stay in a combined insurer and...
Voters in dozens of American cities approved restrictions or outright bans on data centers during Tuesday's midterm elections, in one of the clearest signals that a groundswell of anger over the AI boom has...
WASHINGTON (AP) — President Donald Trump was publicly humbled by inflation in Tuesday’s midterm elections, as rising prices provoked a blistering set of losses for Republicans in House, Senate and gubernatorial races.
By Huileng Tan You're currently following this author! Click to unsubscribe from email alerts. US stocks surged after Democrats won control of Congress in the midterm elections. Michael Nagle/Bloomberg/Getty Images A Democratic Congress may have less influence over markets than investors expect, an economist said. US s